ZYNE - Zynerba Pharmaceuticals GAAP EPS of -$0.21 misses by $0.02 May, 15 2023 09:22 AM Zynerba Pharmaceuticals Inc. 2023-05-15 09:22:25 ET Zynerba Pharmaceuticals press release ( NASDAQ: ZYNE ): Q1 GAAP EPS of -$0.21 misses by $0.02 . $44.4 million in cash and cash equivalents at March 31, 2023; Cash runway to mid-year 2024. For further details see: Zynerba Pharmaceuticals GAAP EPS of -$0.21 misses by $0.02